Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: betty moyers who wrote (10501)	7/6/1998 12:25:00 PM
From: VLAD	Read Replies (3) \| Respond to of 23519

betty, No need to put on your seat belt. The upwards recovery of Vivus will be a slow but steady process. My own targets are 15 to 17 by Q3's report and 22 to 24 (thats right jack, 6 more months) by Q4's report. Based on US script data and info on international sales given on the 9th, the Anal_ysts should be better at estimates as they don't have a clue regarding international sales. Also, remember costs on construction and equipment on the new plant are one time deals taken in up to Q2 and these costs will not be repeated.